Rushika Shah Vipul

Rushika Shah Vipul

Active Director Director DIN 07995110
DIN 07995110 First appointment Jan 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2018
Shareholding value •••• Premium profile

About Rushika Shah Vipul

Data last updated:

Rushika Shah Vipul is a Director at Epione Pharmaceuticals Private Limited (since 2018). The company operates in Pharma. Epione Pharmaceuticals Private Limited reported revenue of ₹12.66 Cr (FY 2024).

DIN 07995110
Primary Designation Director
Industry Pharma
First Appointment 16 Jan 2018
Oldest Company Age 14 yrs
Largest company Epione Pharmaceuticals Private Limited · ₹12.66 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Jan 20182012₹12.66 Cr (FY 2024)Active

Directorship timeline

Open interactive timeline →
Epione Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rushika Shah Vipul

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rushika Shah Vipul

Rushika Shah Vipul currently holds 1 directorship: Epione Pharmaceuticals Private Limited (Director, since 16 Jan 2018, revenue ₹12.66 Cr (FY 2024)).

Rushika Shah Vipul was first appointed on 16 Jan 2018 as Director at Epione Pharmaceuticals Private Limited.

The current boards of Rushika Shah Vipul's companies include Pankaj Shah Sumatilal (Epione Pharmaceuticals Private Limited), Rekha Shah Pankaj (Epione Pharmaceuticals Private Limited), Vipul Shah Pankaj (Epione Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available